Testing effectiveness (Phase 2)WithdrawnNCT02097264
What this trial is testing
A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Who this might be right for
InflammationRheumatoid Arthritis
Novo Nordisk A/S